vs
1 800 FLOWERS COM INC（FLWS）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
1 800 FLOWERS COM INC的季度营收约是Orthofix Medical Inc.的1.3倍（$293.0M vs $219.9M），Orthofix Medical Inc.净利率更高（-1.0% vs -34.1%，领先33.1%），Orthofix Medical Inc.同比增速更快（2.0% vs -11.6%），1 800 FLOWERS COM INC自由现金流更多（$20.0M vs $16.8M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs -12.1%）
1 800 FLOWERS COM INC是美国知名的全渠道鲜花礼品零售企业，主营鲜花花束、礼品篮、美食礼盒、定制礼物及家居装饰品，服务北美地区个人及企业客户，覆盖节日、生日、纪念日等各类送礼场景。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
FLWS vs OFIX — 直观对比
营收规模更大
FLWS
是对方的1.3倍
$219.9M
营收增速更快
OFIX
高出13.6%
-11.6%
净利率更高
OFIX
高出33.1%
-34.1%
自由现金流更多
FLWS
多$3.2M
$16.8M
两年增速更快
OFIX
近两年复合增速
-12.1%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $293.0M | $219.9M |
| 净利润 | $-100.1M | $-2.2M |
| 毛利率 | 33.2% | 71.1% |
| 营业利润率 | 34.5% | 0.2% |
| 净利率 | -34.1% | -1.0% |
| 营收同比 | -11.6% | 2.0% |
| 净利润同比 | 44.3% | 92.4% |
| 每股收益（稀释后） | $-1.56 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FLWSOFIX
| Q1 26 | $293.0M | — | ||
| Q4 25 | $702.2M | $219.9M | ||
| Q3 25 | $215.2M | $205.6M | ||
| Q2 25 | $336.6M | $203.1M | ||
| Q1 25 | $331.5M | $193.6M | ||
| Q4 24 | $775.5M | $215.7M | ||
| Q3 24 | $242.1M | $196.6M | ||
| Q2 24 | — | $198.6M |
净利润FLWSOFIX
| Q1 26 | $-100.1M | — | ||
| Q4 25 | $70.6M | $-2.2M | ||
| Q3 25 | $-53.0M | $-22.8M | ||
| Q2 25 | $-51.9M | $-14.1M | ||
| Q1 25 | $-178.2M | $-53.1M | ||
| Q4 24 | $64.3M | $-29.1M | ||
| Q3 24 | $-34.2M | $-27.4M | ||
| Q2 24 | — | $-33.4M |
毛利率FLWSOFIX
| Q1 26 | 33.2% | — | ||
| Q4 25 | 42.1% | 71.1% | ||
| Q3 25 | 35.7% | 72.2% | ||
| Q2 25 | 35.5% | 68.7% | ||
| Q1 25 | 31.7% | 62.8% | ||
| Q4 24 | 43.3% | 69.0% | ||
| Q3 24 | 38.1% | 68.7% | ||
| Q2 24 | — | 67.8% |
营业利润率FLWSOFIX
| Q1 26 | 34.5% | — | ||
| Q4 25 | 10.6% | 0.2% | ||
| Q3 25 | -23.5% | -8.3% | ||
| Q2 25 | -16.5% | -7.9% | ||
| Q1 25 | -58.4% | -25.2% | ||
| Q4 24 | 11.7% | -5.3% | ||
| Q3 24 | -19.4% | -9.6% | ||
| Q2 24 | — | -12.5% |
净利率FLWSOFIX
| Q1 26 | -34.1% | — | ||
| Q4 25 | 10.0% | -1.0% | ||
| Q3 25 | -24.6% | -11.1% | ||
| Q2 25 | -15.4% | -6.9% | ||
| Q1 25 | -53.8% | -27.4% | ||
| Q4 24 | 8.3% | -13.5% | ||
| Q3 24 | -14.1% | -13.9% | ||
| Q2 24 | — | -16.8% |
每股收益（稀释后）FLWSOFIX
| Q1 26 | $-1.56 | — | ||
| Q4 25 | $1.10 | $-0.05 | ||
| Q3 25 | $-0.83 | $-0.57 | ||
| Q2 25 | $-0.80 | $-0.36 | ||
| Q1 25 | $-2.80 | $-1.35 | ||
| Q4 24 | $1.00 | $-0.76 | ||
| Q3 24 | $-0.53 | $-0.71 | ||
| Q2 24 | — | $-0.88 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $50.7M | $82.0M |
| 总债务越低越好 | $24.0M | — |
| 股东权益账面价值 | $192.5M | $450.0M |
| 总资产 | $679.9M | $850.6M |
| 负债/权益比越低杠杆越低 | 0.12× | — |
8季度趋势，按日历期对齐
现金及短期投资FLWSOFIX
| Q1 26 | $50.7M | — | ||
| Q4 25 | $193.3M | $82.0M | ||
| Q3 25 | $7.7M | $62.9M | ||
| Q2 25 | $46.5M | $65.6M | ||
| Q1 25 | $84.7M | $58.0M | ||
| Q4 24 | $247.2M | $83.2M | ||
| Q3 24 | $8.4M | $30.1M | ||
| Q2 24 | — | $26.4M |
总债务FLWSOFIX
| Q1 26 | $24.0M | — | ||
| Q4 25 | $123.5M | — | ||
| Q3 25 | $128.9M | $157.2M | ||
| Q2 25 | $134.8M | $157.0M | ||
| Q1 25 | $142.3M | $156.9M | ||
| Q4 24 | $157.5M | $157.0M | ||
| Q3 24 | $172.3M | $118.5M | ||
| Q2 24 | — | $118.0M |
股东权益FLWSOFIX
| Q1 26 | $192.5M | — | ||
| Q4 25 | $289.7M | $450.0M | ||
| Q3 25 | $217.5M | $442.5M | ||
| Q2 25 | $268.3M | $458.3M | ||
| Q1 25 | $317.7M | $458.3M | ||
| Q4 24 | $495.1M | $503.1M | ||
| Q3 24 | $433.4M | $525.9M | ||
| Q2 24 | — | $546.0M |
总资产FLWSOFIX
| Q1 26 | $679.9M | — | ||
| Q4 25 | $893.1M | $850.6M | ||
| Q3 25 | $840.5M | $832.6M | ||
| Q2 25 | $772.6M | $837.2M | ||
| Q1 25 | $806.2M | $823.1M | ||
| Q4 24 | $1.1B | $893.3M | ||
| Q3 24 | $1.0B | $867.9M | ||
| Q2 24 | — | $882.0M |
负债/权益比FLWSOFIX
| Q1 26 | 0.12× | — | ||
| Q4 25 | 0.43× | — | ||
| Q3 25 | 0.59× | 0.36× | ||
| Q2 25 | 0.50× | 0.34× | ||
| Q1 25 | 0.45× | 0.34× | ||
| Q4 24 | 0.32× | 0.31× | ||
| Q3 24 | 0.40× | 0.23× | ||
| Q2 24 | — | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $42.9M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $20.0M | $16.8M |
| 自由现金流率自由现金流/营收 | 6.8% | 7.6% |
| 资本支出强度资本支出/营收 | 7.8% | 4.9% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $140.5M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流FLWSOFIX
| Q1 26 | $42.9M | — | ||
| Q4 25 | $309.9M | $27.7M | ||
| Q3 25 | $-139.0M | $12.4M | ||
| Q2 25 | $-27.1M | $11.6M | ||
| Q1 25 | $-150.6M | $-18.4M | ||
| Q4 24 | $328.5M | $23.7M | ||
| Q3 24 | $-177.2M | $11.7M | ||
| Q2 24 | — | $9.0M |
自由现金流FLWSOFIX
| Q1 26 | $20.0M | — | ||
| Q4 25 | $302.2M | $16.8M | ||
| Q3 25 | $-145.6M | $2.5M | ||
| Q2 25 | $-36.1M | $4.5M | ||
| Q1 25 | $-160.0M | $-25.1M | ||
| Q4 24 | $317.6M | $15.2M | ||
| Q3 24 | $-189.3M | $6.3M | ||
| Q2 24 | — | $-360.0K |
自由现金流率FLWSOFIX
| Q1 26 | 6.8% | — | ||
| Q4 25 | 43.0% | 7.6% | ||
| Q3 25 | -67.7% | 1.2% | ||
| Q2 25 | -10.7% | 2.2% | ||
| Q1 25 | -48.3% | -13.0% | ||
| Q4 24 | 41.0% | 7.0% | ||
| Q3 24 | -78.2% | 3.2% | ||
| Q2 24 | — | -0.2% |
资本支出强度FLWSOFIX
| Q1 26 | 7.8% | — | ||
| Q4 25 | 1.1% | 4.9% | ||
| Q3 25 | 3.1% | 4.8% | ||
| Q2 25 | 2.7% | 3.5% | ||
| Q1 25 | 2.8% | 3.5% | ||
| Q4 24 | 1.4% | 4.0% | ||
| Q3 24 | 5.0% | 2.7% | ||
| Q2 24 | — | 4.7% |
现金转化率FLWSOFIX
| Q1 26 | — | — | ||
| Q4 25 | 4.39× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 5.11× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FLWS
| Consumer Floral & Gifts | $159.4M | 54% |
| Gourmet Foods & Gift Baskets | $106.9M | 36% |
| BloomNet | $26.9M | 9% |
| Corporate | $50.0K | 0% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
